Table of Content

Executive Summary
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note

1. Global Intermediate Age-Related Macular Degeneration Market: Industry Outlook
1.1 Introduction
1.2 Market Trends
1.3 Regulatory Framework
1.4 Epidemiology of Intermediate Age-Related Macular Degeneration
1.5 Clinical Trial Analysis
1.6 Market Dynamics
1.6.1 Impact Analysis
1.6.2 Market Drivers
1.6.3 Market Challenges
1.6.4 Market Opportunities

2. Global Intermediate Age-Related Macular Degeneration Market, by Region, $Million, 2023-2035
2.1 North America
2.1.1 Key Findings
2.1.2 Market Dynamics
2.1.3 Market Sizing and Forecast
2.1.3.1 North America Intermediate Age-Related Macular Degeneration Market, by Country
2.1.3.1.1 U.S.
2.2 Europe
2.2.1 Key Findings
2.2.2 Market Dynamics
2.2.3 Market Sizing and Forecast
2.2.3.1 Europe Intermediate Age-Related Macular Degeneration Market, by Country
2.2.3.1.1 Germany
2.2.3.1.2 U.K.
2.2.3.1.3 France
2.2.3.1.4 Italy
2.2.3.1.5 Spain
2.3 Asia Pacific
2.3.1 Key Findings
2.3.2 Market Dynamics
2.3.3 Market Sizing and Forecast
2.3.3.1 Asia Pacific Intermediate Age-Related Macular Degeneration Market, by Country
2.3.3.1.1 Japan

3. Global Intermediate Age-Related Macular Degeneration Market: Competitive Landscape and Company Profiles
3.1 Key Developments and Strategies
3.1.1 Mergers and Acquisitions
3.1.2 Synergistic Activities
3.1.3 Business Expansions and Funding
3.1.4 Product Launches and Approvals
3.1.5 Other Activities
3.2 Company Profiles
3.2.1 Novartis AG
3.2.1.1 Overview
3.2.1.2 Top Products / Product Portfolio
3.2.1.3 Target Customers/End-Users
3.2.1.4 Key Personnel
3.2.1.5 Analyst View
3.2.2 Allegro Ophthalmics, LLC.
3.2.2.1 Overview
3.2.2.2 Top Products / Product Portfolio
3.2.2.3 Target Customers/End-Users
3.2.2.4 Key Personnel
3.2.2.5 Analyst View
3.2.3 Apellis Pharmaceuticals
3.2.3.1 Overview
3.2.3.2 Top Products / Product Portfolio
3.2.3.3 Target Customers/End-Users
3.2.3.4 Key Personnel
3.2.3.5 Analyst View

4. Research Methodology

List of Figures
Figure: Global Intermediate Age-Related Macular Degeneration Market (by Region), $Million, 2024 and 2035
Figure: Epidemiology of Intermediate Age-Related Macular Degeneration
Figure: Global Intermediate Age-Related Macular Degeneration Market Coverage
Figure: Global Intermediate Age-Related Macular Degeneration Market Key Trends, Impact Analysis, 2023-2035
Figure: Global Intermediate Age-Related Macular Degeneration Market, Competitive Landscape, January 2022-April 2025

List of Tables
Table: Global Intermediate Age-Related Macular Degeneration Market, Clinical Trial Analysis
Table: Global Intermediate Age-Related Macular Degeneration Market Dynamics, Impact Analysis
Table: Global Intermediate Age-Related Macular Degeneration Market (by Region), $Million, 2023-2035